Therapeutic potential of a plant-made cholera toxin b subunit variant for the treatment of ulcerative colitis.

@inproceedings{Royal2018TherapeuticPO,
  title={Therapeutic potential of a plant-made cholera toxin b subunit variant for the treatment of ulcerative colitis.},
  author={Joshua M. Royal},
  year={2018}
}
S AND PRESENTATIONS Oral Presentations: National/International Meetings 1. Royal J, Baldauf K, Kouokam J, Matoba N. “Plant-made cholera toxin B subunit as a candidate oral immunotherapeutic agent against ulcerative colitis” PlantBased Vaccines, Antibodies & Biologics. June 8 – 10, 2015, Lausanne, Switzerland. 2. Royal J, Oh Y, Galandiuk S, Matoba N. “Epicertin, A Cholera Toxin B Subunit variant, Enhances Intestinal Would Healing in a Mouse Acute Colitis Model and Human Ulcerative Colitis Colon… CONTINUE READING

References

Publications referenced by this paper.
SHOWING 1-10 OF 143 REFERENCES

Oral administration of recombinant cholera toxin subunit B inhibits IL-12-mediated murine experimental (trinitrobenzene sulfonic acid) colitis

M Boirivant
  • J Immunol,
  • 2001
VIEW 12 EXCERPTS
HIGHLY INFLUENTIAL